These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7697778)

  • 1. Synthesis and human immunodeficiency virus (HIV)-1 protease inhibitory activity of tripeptide analogues containing a dioxoethylene moiety.
    Kitazaki T; Asano T; Kato K; Kishimoto S; Itoh K
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2636-40. PubMed ID: 7697778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid.
    Marastoni M; Fantin G; Bortolotti F; Tomatis R
    Arzneimittelforschung; 1996 Nov; 46(11):1099-101. PubMed ID: 8955873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of di- and tripeptide analogues containing alpha-ketoamide as a new core structure for inhibition of HIV-1 protease.
    Sheha MM; Mahfouz NM; Hassan HY; Youssef AF; Mimoto T; Kiso Y
    Eur J Med Chem; 2000 Oct; 35(10):887-94. PubMed ID: 11121614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 protease inhibitors containing statine: inhibitory potency and antiviral activity.
    Fehrentz JA; Chomier B; Bignon E; Venaud S; Chermann JC; Nisato D
    Biochem Biophys Res Commun; 1992 Oct; 188(2):865-72. PubMed ID: 1445327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands.
    Jungheim LN; Shepherd TA; Baxter AJ; Burgess J; Hatch SD; Lubbehusen P; Wiskerchen M; Muesing MA
    J Med Chem; 1996 Jan; 39(1):96-108. PubMed ID: 8568831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of HIV protease inhibitors containing allophenylnorstatine as a transition-state mimic.
    Kiso Y
    Adv Exp Med Biol; 1995; 362():413-23. PubMed ID: 8540352
    [No Abstract]   [Full Text] [Related]  

  • 7. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
    Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses of HIV-protease inhibitors having a peptide moiety which binds to GP120.
    Asagarasu A; Uchiyama T; Achiwa K
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):697-703. PubMed ID: 9579045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors.
    Marastoni M; Bazzaro M; Bortolotti F; Tomatis R
    Arzneimittelforschung; 2000 Jun; 50(6):564-8. PubMed ID: 10918952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors.
    Narendra Babu SN; Rangappa KS
    Bioorg Med Chem; 2008 Jan; 16(2):874-80. PubMed ID: 17981043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fast and robust 19F NMR-based method for finding new HIV-1 protease inhibitors.
    Frutos S; Tarrago T; Giralt E
    Bioorg Med Chem Lett; 2006 May; 16(10):2677-81. PubMed ID: 16517158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA.
    Sakurai M; Higashida S; Sugano M; Komai T; Yagi R; Ozawa Y; Handa H; Nishigaki T; Yabe Y
    Bioorg Med Chem; 1994 Aug; 2(8):807-25. PubMed ID: 7894975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.
    Hidaka K; Kimura T; Abdel-Rahman HM; Nguyen JT; McDaniel KF; Kohlbrenner WE; Molla A; Adachi M; Tamada T; Kuroki R; Katsuki N; Tanaka Y; Matsumoto H; Wang J; Hayashi Y; Kempf DJ; Kiso Y
    J Med Chem; 2009 Dec; 52(23):7604-17. PubMed ID: 19954246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity.
    Thaisrivongs S; Tomasselli AG; Moon JB; Hui J; McQuade TJ; Turner SR; Strohbach JW; Howe WJ; Tarpley WG; Heinrikson RL
    J Med Chem; 1991 Aug; 34(8):2344-56. PubMed ID: 1875334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An expedient synthesis of N(alpha)-protected-L-tetrahydrofuranylglycine and its application in the synthesis of novel substrate based inhibitors of HIV-1 protease.
    Rajesh S; Ami E; Kotake T; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3615-7. PubMed ID: 12443788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV protease inhibitors: synthesis and activity of N-aryl-N'-hydroxyalkyl hydrazide pseudopeptides.
    Marastoni M; Baldisserotto A; Trapella C; McDonald J; Bortolotti F; Tomatis R
    Eur J Med Chem; 2005 May; 40(5):445-51. PubMed ID: 15893018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidomimetic inhibitors complexed with HIV-1 protease: crystallisation for X-ray diffraction studies.
    Dohnálek J; Hasek J; Brynda J; Fábry M; Sedlácek J; Konvalinka J; Hradilek M; Soucek M; Adams MJ; Naylor CE
    Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():9-11. PubMed ID: 9789742
    [No Abstract]   [Full Text] [Related]  

  • 18. Statine based tripeptides as potent inhibitors of HIV-1 replication.
    Fehrentz JA; Chomier B; Bignon E; Venaud S; Chermann JC; Nisato D
    Biochem Biophys Res Commun; 1992 Oct; 188(2):873-8. PubMed ID: 1445328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of human immunodeficiency virus type 1 (HIV-1) protease inhibitors. III. Structure-activity relationship of HIV-1 protease inhibitors containing cyclohexylalanylalanine hydroxyethylene dipeptide isostere.
    Sakurai M; Higashida S; Sugano M; Handa H; Komai T; Yagi R; Nishigaki T; Yabe Y
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):534-40. PubMed ID: 8004698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.
    Qiu X; Zhao GD; Tang LQ; Liu ZP
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2465-8. PubMed ID: 24767846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.